The clinical impact of bacteremia in complicated acute pyelonephritis

American Journal of the Medical Sciences

Volumn 332, Issue 4, 2006, Pages 175-180

  Hsu, Chih Yang ^b   Fang, Hua Chang ^b   Chou, Kang Ju ^b   Chen, Chien Liang ^b   Lee, Po Tsang ^a   Chung, Hsiao Min ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Acute pyelonephritis; Bacteremia; Complicated; Disease severity

Indexed keywords

ANTIBIOTIC AGENT; SERUM ALBUMIN;

ACUTE PYELONEPHRITIS; ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY DYSFUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUTROPHIL COUNT; NONHUMAN; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TAIWAN; TREATMENT DURATION; URINARY TRACT INFECTION; UROLITHIASIS;

ACUTE DISEASE; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; DIABETES MELLITUS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PYELONEPHRITIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 33749868130     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200610000-00004     Document Type: Article

References (34)

1. Ronald AR, Nicollé LE. Infections of the Upper Urinary Tract. In: Schrier RW, editor. Disease of the Kidney and Urinary Tract. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001:p.941-69.
2. Bergeron MG. Treatment of pyelonephritis in adults. Med Clin North Am 1995;79:619-49.
3. Gleckman RA, Bradley PJ, Roth RM, et al. Bacteremic urosepsis: a phenomenon unique to elderly women. J Urol 1985;133:174-5.
4. Jerkeman M, Braconier JH. Bacteremic and non-bacteremic febrile urinary tract infection-a review of 168 hospital-treated patients. Infection 1992;20:143-5.
5. Smith WR, McClish DK, Poses RM, et al. Bacteremia in young urban women admitted with pyelonephritis. Am J Med Sci 1997;313:50-7.
6. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988;85:793-8.
7. Pinson AG, Philbrick JT, Lindbeck GH, et al. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med 1994;12:271-8.
8. Mombelli G, Pezzoli R, Pinoja-Lutz G, et al. Oral vs. intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999;159:53-8.
9. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003;13:144-50.
10. Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132:490-3.
11. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132:494-8.
12. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991;13:34-46.
13. Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 1987;63:427-40.
14. Leibovici L, Greenshtain S, Cohen O, et al. Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992;152:2481-6.
15. Leibovici L, Greenshtain S, Cohen O, et al. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med 1991;151:1801-6.
16. McMurray BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med 1997;15:137-40.
17. Thanassi M. Utility of urine and blood cultures in pyelonephritis. Acad Emerg Med 1997;4:797-800.
18. Velasco M, Martinez JA, Moreno-Martinez A, et al. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis 2003;37:1127-30.
19. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
20. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
21. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23.
22. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;26(Suppl 1):S64-74.
23. Pittet D, Rangel-Frausto S, Li N, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995;21:302-9.
24. Ruot B, Bechereau F, Bayle G, et al. The response of liver albumin synthesis to infection in rats varies with the phase of the inflammatory process. Clin Sci 2002;102:107-14.
25. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet 1985;1:781-4.
26. Herrmann FR, Safran C, Levkoff SE, et al. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992;152:125-30.
27. Vincent JL, Dubois MJ, Navickis RJ, et al. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-34.
28. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154:617-24.
29. Gransden WR, Eykyn SJ, Phillips I, et al. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis 1990;12:1008-18.
30. Bergeron MG, Brusch JL, Barza M, et al. Bactericidal activity and pharmacology of cefazolin. Antimicrob Agents Chemother 1973;4:396-401.
31. Ries K, Levison ME, Kaye D. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother 1973;3:168-74.
32. Bergeron MG, Marois Y. Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. Kidney Int 1986;30:481-7.
33. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58.
34. Cattell WR. Lower and Upper Urinary Tract Infections in the Adult. In: Davison AM, editor. Oxford Textbook of Clinical Nephrology. 3th ed. New York: Oxford University Press; 2005: p.1111-29.